FORM 6-K

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

For the month of ….  

 January

  ……………………………………………… ,   

2018

 

 

   CANON INC.   
   (Translation of registrant’s name into English)   
   30-2, Shimomaruko 3-Chome, Ohta-ku, Tokyo 146-8501, Japan   
   (Address of principal executive offices)   

[Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F

  X   Form 40-F     

[Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes

      

No

  X

[If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):82-....................


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

CANON INC.

 
    (Registrant)  

 

Date….

  January 30, 2018             By……/s/……………Eiji Shimizu………
                                                               (Signature)*
        
        
        
        
        

                     Eiji Shimizu

                     General Manager

                     Consolidated Accounting Div.

                     Canon Inc.

*Print the name and title of the signing officer under his signature.

The following materials are included.

 

1.  RESULTS FOR THE FOURTH QUARTER AND THE FISCAL YEAR ENDED DECEMBER 31, 2017


LOGO

RESULTS FOR THE FOURTH QUARTER

AND THE FISCAL YEAR ENDED DECEMBER 31, 2017

January 30, 2018

CONSOLIDATED RESULTS

        (Millions of yen, thousands of U.S. dollars, except per share amounts)  
  

 

Actual

 

  

 

Projected

 

     Year ended
December 31,
2017
     Year ended
December 31,
2016
     Change(%)     Year ended
December 31, 2017
     Year ending
December 31,
2018
     Change(%)  

Net sales

   ¥ 4,080,015        ¥ 3,401,487          +       19.9       $ 36,106,327        ¥ 4,300,000          +        5.4    

Operating profit

     331,479          228,866          +       44.8         2,933,442          420,000          +        26.7    

Income before income taxes

     353,884          244,651          +       44.6         3,131,717          420,000          +        18.7    

Net income attributable

                         to Canon Inc.

   ¥ 241,923        ¥ 150,650          +       60.6       $ 2,140,912        ¥ 280,000          +        15.7    
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Net income attributable to Canon Inc. shareholders per share:

 

          

- Basic

   ¥ 222.88        ¥ 137.95          +       61.6       $ 1.97        ¥ 259.32          +        16.3  

- Diluted

     222.88          137.95          +       61.6         1.97          -               -      
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 
     Actual         
     As of
December 31,
2017
     As of
December 31,
2016
     Change(%)     As of
December 31, 2017
    

Total assets

   ¥ 5,198,291      ¥ 5,138,529        +       1.2     $ 46,002,575     
  

 

 

    

 

 

    

 

 

   

 

 

    

Canon Inc. shareholders’ equity

   ¥ 2,870,630      ¥ 2,783,129        +       3.1     $ 25,403,805     
  

 

 

    

 

 

    

 

 

   

 

 

    

 

Notes:    1.    Canon’s consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles.
   2.    U.S. dollar amounts are translated from yen at the rate of JPY 113= U.S.$1, the approximate exchange rate on the Tokyo Foreign Exchange Market as of December 29, 2017, solely for the convenience of the reader.

 

   

Canon Inc.

   30-2, Shimomaruko 3-chome, Ohta-ku,

Headquarter office

   Tokyo 146-8501, Japan
   Phone: +81-3-3758-2111

 

- 1 -


I. Operating Results and Financial Conditions

2017 in Review

Looking back at the global economy in 2017, the U.S. economy continued to grow steadily as employment conditions and corporate earnings improved. In Europe, the economy remained stable as unemployment rates decreased and capital investment increased due to strong exports. The Chinese economy rallied due to public investments while the economies of emerging countries realized moderate recovery as the economies of Russia and Brazil bottomed out owing to the rising price of natural resources. In Japan, corporate earnings improved and consumer spending showed signs of recovery. As a result, the global economy overall continued to recover more robustly than was expected at the beginning of the year.

As for the markets in which Canon operates amid these conditions, demand for office multifunction devices (MFDs) and laser printers remained at around the same level as the previous year. While demand for cameras shrank moderately, demand for inkjet printers increased from the previous year with the economies recovering in emerging countries. Additionally, there was solid demand for medical equipment, mainly outside of Japan. Within the Industry and Others sector, demand for flat panel display (FPD) lithography equipment and manufacturing equipment for organic LED (OLED) panels enjoyed strong growth and the demand for network camera also enjoyed solid growth.

The average value of the yen during the year was ¥112.13 against the U.S. dollar, a year-on-year depreciation of approximately ¥4, and ¥126.69 against the euro, a year-on-year depreciation of approximately ¥6.

During 2017, unit sales of office MFDs increased compared with the previous year due to the expanded sales of color models. Additionally, unit sales of laser printers increased compared with the previous year, supported by the steady sales of newly launched models, as demand recovered in emerging countries. While unit sales of interchangeable-lens digital cameras decreased compared with the previous year, unit sales of digital compact cameras remained at around the same level amid the shrinking market, owing to increased sales of high-value-added models. Looking at inkjet printers, unit sales increased compared with the previous year, thanks to such factors as strong sales of newly launched home-use models and refillable ink tank models for emerging countries. Additionally, sales of semiconductor lithography equipment, FPD lithography equipment, and manufacturing equipment for OLED panels exceeded those of the previous year, thanks to favorable market conditions, and sales of network cameras increased steadily in response to the growing market. Under these conditions, along with the impact of acquiring Toshiba Medical Systems Corporation (TMSC) (Canon Medical Systems Corporation as of January 4th, 2018), net sales for the year increased by 19.9% year on year to ¥4,080.0 billion. Although the gross profit ratio decreased by 0.4 points to 48.8% due to the effect of the product mix, gross profit increased by 19.0% year on year to ¥1,992.7 billion, thanks to such factors as the increase in sales and continuous cost reduction efforts. Operating expenses increased by 15.0% year on year, mainly due to impairment loss on goodwill of commercial printing business in Office Business Unit and the impact of acquiring TMSC. As a result, operating profit increased by 44.8% to ¥331.5 billion. Adjusted operating profit, which excludes impairment losses on goodwill from operating profit as they are considered nonrecurring charges, increased by 59.7% to ¥365.4 billion. Other income (deductions) increased by ¥6.6 billion mainly due to gain on securities contributed to retirement benefit trust and foreign currency exchange losses while income before income taxes increased by 44.6% year on year to ¥353.9 billion and net income attributable to Canon Inc. increased by 60.6% to ¥241.9 billion.

Basic net income attributable to Canon Inc. shareholders per share for the year was ¥222.88, a year-on-year increase of ¥84.93.

 

- 2 -


Results by Segment

Looking at Canon’s full-year performance by business unit, beginning with the Office Business Unit, unit sales of office MFDs increased from the previous year and achieved higher growth than the market average, supported by steady sales of next-generation color models designed to strengthen the product lineup such as the newly launched color A3 (12”x18”) imageRUNNER ADVANCE C3500 series for small- and medium-size offices. Among high-speed continuous-feed printers, unit sales of the Océ-produced VarioPrint i300, a high-speed sheet-fed color inkjet press that offers superior low-running-cost performance, increased. As for laser printers, sales of both hardware and consumables increased from the previous year, supported by steady sales of new models that achieve low power consumption and compact body designs. These factors resulted in total sales for the business unit of ¥1,865.9 billion, a year-on-year increase of 3.2%, while operating profit totaled ¥180.6 billion, a year-on-year increase of 6.6%. Adjusted operating profit, which excludes impairment losses on goodwill from operating profit, increased by 26.6% to ¥214.6 billion.

Within the Imaging System Business Unit, while the pace of decline in demand for interchangeable-lens digital cameras is gradually decelerating, the sales of the advanced-amateur-models —including the EOS 6D Mark II—enjoyed solid demand, allowing Canon to maintain the top share, mainly in the United States, Europe, and Japan. As for compact-system cameras, the advanced-amateur-model EOS M6 and the entry-level EOS M100 enjoyed strong demand. As for digital compact cameras, amid the shrinking market, unit sales remained at the same level as the previous year, supported by the increased sales of such high-value-added models as the newly launched G9 X Mark II—part of the high-image-quality PowerShot G-series lineup. As for inkjet printers, the newly designed home-use TS-series, refillable ink tank models targeting emerging countries and the imagePROGRAF PRO series of large format inkjet printer targeting the professional photo and graphic art markets enjoyed strong demand, resulting in unit sales increasing from the previous year. As a result, sales for the business unit increased by 3.7% year on year to ¥1,136.2 billion, while operating profit totaled ¥175.9 billion, a year-on-year increase of 21.8%.

Within the Medical System Business Unit, TMSC’s computed tomography (CT) products increased the sales and maintained the top share in the Japanese market thanks to the solid sales of the newly launched Aquilion Precision CT scanner, which delivers the industry’s highest level of high-resolution imaging. As for diagnostic ultrasound systems, sale of the Aplio i-series, which delivers proprietary high-resolution imaging technology, remained firm. As a result, sales for the business unit totaled ¥436.2 billion, while operating profit totaled ¥22.5 billion.

In the Industry and Others Business Unit, unit sales of semiconductor lithography equipment increased from the previous year as a result of increasing demand for memory devices used in data centers. Additionally, sales of FPD lithography equipment and manufacturing equipment for OLED panels increased significantly in response to continued growing demand for high-definition OLED displays used in mobile devices. As for network cameras, amid increasing market demand, Axis enjoyed solid sales, resulting in a considerable sales increase compared with the previous year. Consequently, sales for the business unit increased by 25.2% year on year to ¥731.7 billion, while operating profit grew by ¥49.3 billion from the previous year to ¥56.8 billion.

Cash Flow

During 2017, cash flow from operating activities totaled ¥590.6 billion, an increase of ¥90.3 billion compared with the previous year, mainly owing to improvements in profitability. Cash flow from investing activities decreased by ¥672.1 billion year on year to ¥165.0 billion due to the payment made in the previous year for the right to acquire all of the shares of TMSC. Accordingly, free cash flow totaled ¥425.5 billion, an increase of ¥762.4 billion compared with the corresponding year-ago period.

Cash flow from financing activities recorded an outlay of ¥340.5 billion, mainly owing to the dividend payout, the repurchasing of treasury stock and the repayment of long-term debt.

Owing to these factors, as well as the impact of foreign currency translation adjustments, cash and cash equivalents increased by ¥91.6 billion to ¥721.8 billion from the end of the previous year.

 

- 3 -


Outlook

As for the outlook for 2018, the U.S. economy is expected to recover stronger as corporate earnings and capital investments steadily improve thanks to tax reform. The European economy is expected to recover slowly due to increasing uncertainty surrounding the U.K.’s decision to leave the EU, although consumer spending is expected to remain stable due to solid employment conditions. Looking at China, the economy is expected to stabilize through public investments and solid consumer spending. Emerging economies, including Southeast Asia, are expected to continue to grow due to strong exports. With regard to the Japanese economy, the outlook indicates a trend of gradual recovery supported by improved employment conditions and consumer spending. Overall, the global economy is expected to continue achieving moderate growth, despite such concerns as increasing geopolitical risks.

In the businesses in which Canon is involved, for office MFDs, demand for color models is expected to grow moderately and make up for the contraction of the market for monochrome models, leading to the same level of demand overall compared with the previous year. Looking at the laser printer market, although the demand in developed countries is expected to decrease, demand in emerging countries continues to recover, resulting in overall demand remaining at the same level as the previous year. For interchangeable-lens digital cameras, demand is expected to decrease moderately. Projections for digital compact cameras indicate continued market contraction, centered mainly on low-priced models, despite solid demand for high-value-added models. With regard to inkjet printers, demand is expected to continue to exceed that of the previous year. As for the medical equipment market, demand is expected to remain firm in response to replacement demand for medical equipment in developed countries, increasing medical needs associated with population growth in emerging countries and changes in the prevalence of diseases. Looking at industrial equipment, within the semiconductor lithography equipment segment, the market is expected to enjoy healthy growth due to the increase in demand for memory devices used in data centers and mobile devices. The outlook for FPD lithography equipment and OLED panel manufacturing equipment points to continued active capital investment by panel manufacturers, which is expected to increase demand. The network camera market is also expected to grow in response to the increasing use of network cameras for diverse applications in such areas as marketing support in addition to disaster monitoring and crime prevention applications.

With regard to currency exchange rates for the year, on which Canon’s performance outlook is based, Canon anticipates exchange rates of ¥110 to the U.S. dollar and ¥130 to the euro, representing appreciation of approximately ¥2 against the U.S. dollar and depreciation of approximately ¥3 against the euro compared with the annual average rates of the previous year.

Upon taking into consideration the current economic forecast, Canon projects full-year consolidated net sales in 2018 of ¥4,300.0 billion, a year-on-year increase of 5.4%; operating profit of ¥420.0 billion, a year-on-year increase of 26.7%; income before income taxes of ¥420.0 billion, a year-on-year increase of 18.7%; and net income attributable to Canon Inc. of ¥280.0 billion, a year-on-year increase of 15.7%.

 

- 4 -


This document contains forward-looking statements with respect to future results, performance and achievements that are subject to risk and uncertainties and reflect management’s views and assumptions formed by available information. All statements other than statements of historical fact are statements that could be considered forward-looking statements. When used in this document, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “project” or “should” and similar expressions, as they relate to Canon, are intended to identify forward-looking statements. Many factors could cause the actual results, performance or achievements of Canon to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, changes in general economic and business conditions, changes in currency exchange rates and interest rates, introduction of competing products by other companies, lack of acceptance of new products or services by Canon’s targeted customers, inability to meet efficiency and cost reduction objectives, changes in business strategy and various other factors, both referenced and not referenced in this document. A detailed description of these and other risk factors is included in Canon’s annual report on Form 20-F, which is on file with the United States Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein. Canon does not intend or assume any obligation to update these forward-looking statements.

II. Basic Concept Regarding the Selection of Accounting Standards

Canon is listed on the New York Stock Exchange and, since registering its American Depositary Receipts on the OTC (over-the-counter) market in 1969, has prepared its consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) over the long term.

Canon has continued to adopt U.S. GAAP in order to maintain the continuity of financial statements from the past and to maintain international comparability.

 

- 5 -


CANON INC. AND SUBSIDIARIES

CONSOLIDATED

III. Financial Statements

1. CONSOLIDATED BALANCE SHEETS

 

     Millions of yen  
     As of
December 31, 2017
     As of
December 31, 2016
             Change          

ASSETS

        

Current assets:

        

Cash and cash equivalents

     721,814         630,193           91,621     

Short-term investments

     1,965         3,206           (1,241)    

Trade receivables, net

     650,872         641,458           9,414     

Inventories

     570,033         560,736           9,297     

Prepaid expenses and other current assets

     287,965         264,155           23,810     
  

 

 

    

 

 

    

 

 

 

Total current assets

     2,232,649           2,099,748           132,901     

Noncurrent receivables

     35,444           29,297           6,147     

Investments

     48,320           73,680           (25,360)    

Property, plant and equipment, net

     1,126,620           1,194,976           (68,356)    

Intangible assets, net

     420,972           446,268           (25,296)    

Goodwill

     936,722           936,424           298     

Other assets

     397,564           358,136           39,428     
  

 

 

    

 

 

    

 

 

 

Total assets

                     5,198,291                           5,138,529                           59,762     
  

 

 

    

 

 

    

 

 

 

LIABILITIES AND EQUITY

        

Current liabilities:

        

Short-term loans and current portion of long-term debt

     39,328         1,850           37,478     

Trade payables

     380,654           372,269           8,385     

Accrued income taxes

     77,501           30,514           46,987     

Accrued expenses

     330,188           304,901           25,287     

Other current liabilities

     281,809           273,835           7,974     
  

 

 

    

 

 

    

 

 

 

Total current liabilities

     1,109,480           983,369           126,111     

Long-term debt, excluding current installments

     493,238           611,289           (118,051)    

Accrued pension and severance cost

     365,582           407,200           (41,618)    

Other noncurrent liabilities

     133,816           142,049           (8,233)    
  

 

 

    

 

 

    

 

 

 

Total liabilities

     2,102,116           2,143,907           (41,791)     
  

 

 

    

 

 

    

 

 

 

Equity:

        

Canon Inc. shareholders’ equity:

        

Common stock

     174,762           174,762           -       

Additional paid-in capital

     401,386           401,385           1     

Legal reserve

     66,879           66,558           321     

Retained earnings

     3,429,312           3,350,728           78,584     

Accumulated other comprehensive income (loss)

     (143,228)          (199,881)          56,653     

Treasury stock, at cost

     (1,058,481)          (1,010,423)          (48,058)    
  

 

 

    

 

 

    

 

 

 

Total Canon Inc. shareholders’ equity

     2,870,630           2,783,129           87,501     

Noncontrolling interests

     225,545           211,493           14,052     
  

 

 

    

 

 

    

 

 

 

Total equity

     3,096,175           2,994,622           101,553     
  

 

 

    

 

 

    

 

 

 

Total liabilities and equity

     5,198,291           5,138,529           59,762     
  

 

 

    

 

 

    

 

 

 
    

 

Millions of yen

        
     As of
December 31, 2017
     As of
December 31, 2016
        

Notes:

        

1. Allowance for doubtful receivables

     13,378           11,075        

2. Accumulated depreciation

     2,638,055           2,578,342        

3. Accumulated other comprehensive income (loss):

        

Foreign currency translation adjustments

     30,208           (13,960)       

Net unrealized gains and losses on securities

     5,484           15,251        

Net gains and losses on derivative instruments

     (180)          (2,742)       

Pension liability adjustments

     (178,740)          (198,430)       

 

- 6 -


CANON INC. AND SUBSIDIARIES

CONSOLIDATED

2. CONSOLIDATED STATEMENTS OF INCOME AND

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

 

Consolidated statements of income

      
Results for the fourth quarter    Millions of yen        
     Three months
ended
December 31, 2017
    Three months
ended
December 31, 2016
    Change(%)

 

 

 

Net sales

     1,120,291       965,173       +        16.1    

Cost of sales

     573,730       505,066       
  

 

 

   

 

 

      

Gross profit

     546,561       460,107       +        18.8    

Operating expenses:

         

Selling, general and administrative expenses

     346,804       305,987       

Research and development expenses

     86,809       73,952       

Impairment losses on goodwill

     33,912             
  

 

 

   

 

 

      
     467,525       379,939       
  

 

 

   

 

 

      

Operating profit

     79,036       80,168       -        1.4    

Other income (deductions):

         

Interest and dividend income

     1,478       1,178       

Interest expense

     (236     (219     

Other, net

     8,239       (8,492     
  

 

 

   

 

 

      
     9,481       (7,533     
  

 

 

   

 

 

      

Income before income taxes

     88,517       72,635       +        21.9    

Income taxes

     28,776       22,751       
  

 

 

   

 

 

      

Consolidated net income

     59,741       49,884       

Less: Net income attributable to noncontrolling interests

     5,138       5,054       
  

 

 

   

 

 

      

Net income attributable to Canon Inc.

     54,603       44,830       +        21.8    
  

 

 

   

 

 

      

 

Note

         

 

Canon includes “Adjusted operating profit,” which is a non-U.S. GAAP measure, in its disclosure. We believe this measure helps investors better understand Canon’s recurring business performance. A reconciliation from Operating profit to Adjusted operating profit is set forth on the following table.

 

 

Reconciliation from Operating profit to Adjusted operating profit

 

     Millions of yen               
     Three months
ended
December 31, 2017
    Three months
ended
December 31, 2016
              

Operating profit

     79,036       80,168       

Impairment losses on goodwill

     33,912             
  

 

 

   

 

 

      

Adjusted operating profit

     112,948       80,168       
  

 

 

   

 

 

      

 

- 7 -


CANON INC. AND SUBSIDIARIES

CONSOLIDATED

Consolidated statements of income       

Results for the fiscal year

   Millions of yen    
     Year ended
December 31, 2017
   

Year ended
December 31, 2016

 

Change(%)

 

 

Net sales

     4,080,015        3,401,487      +        19.9

Cost of sales

     2,087,324        1,727,654     

Gross profit

     1,992,691        1,673,833      +        19.0
  

 

 

   

 

 

Operating expenses:

      

Selling, general and administrative expenses

     1,297,247        1,142,591     

Research and development expenses

     330,053        302,376     

Impairment losses on goodwill

     33,912        -    
  

 

 

   

 

 
     1,661,212        1,444,967     
  

 

 

   

 

 

Operating profit

     331,479        228,866      +        44.8

Other income (deductions):

      

Interest and dividend income

     6,012        4,762     

Interest expense

     (818)       (1,061)    

Other, net

     17,211        12,084     
  

 

 

   

 

 
     22,405        15,785     
  

 

 

   

 

 

Income before income taxes

     353,884        244,651      +        44.6

Income taxes

     98,024        82,681     
  

 

 

   

 

 

Consolidated net income

     255,860        161,970     

Less: Net income attributable to noncontrolling interests

     13,937        11,320     
  

 

 

   

 

 

Net income attributable to Canon Inc.

     241,923        150,650      +        60.6
  

 

 

   

 

 

 

Note

Canon includes “Adjusted operating profit,” which is a non-U.S. GAAP measure, in its disclosure. We believe this measure helps investors better understand Canon’s recurring business performance. A reconciliation from Operating profit to Adjusted operating profit is set forth on the following table.

 

Reconciliation from Operating profit to Adjusted operating profit

     Millions of yen    
     Year ended
December 31, 2017
   

Year ended
December 31, 2016

   

Operating profit

     331,479        228,866     

Impairment losses on goodwill

     33,912        -    
  

 

 

   

 

 

Adjusted operating profit

     365,391        228,866     
  

 

 

   

 

 

 

- 8 -


CANON INC. AND SUBSIDIARIES

CONSOLIDATED

Consolidated statements of comprehensive income       

Results for the fourth quarter

   Millions of yen    
     Three months
ended
December 31, 2017
   

Three months

ended
December 31, 2016

 

Change(%)

 

 

Consolidated net income

     59,741        49,884      +        19.8

Other comprehensive income (loss), net of tax:

      

Foreign currency translation adjustments

     9,001        189,007     

Net unrealized gains and losses on securities

     (4,859)       5,184     

Net gains and losses on derivative instruments

     909        (4,514)    

Pension liability adjustments

     20,975        (72,975)    
  

 

 

   

 

 
     26,026        116,702     
  

 

 

   

 

 

Comprehensive income (loss)

     85,767        166,586      -      48.5

Less: Comprehensive income attributable to noncontrolling interests

     7,731        5,584     
  

 

 

   

 

 

Comprehensive income (loss) attributable to Canon Inc.

     78,036        161,002      -        51.5
  

 

 

   

 

 

 

Results for the fiscal year

   Millions of yen    
     Year ended
December 31, 2017
   

Year ended
December 31, 2016

 

Change(%)

 

Consolidated net income

     255,860        161,970     +        58.0

Other comprehensive income (loss), net of tax:

      

Foreign currency translation adjustments

     47,090        (107,666)    

Net unrealized gains and losses on securities

     (9,362)       997     

Net gains and losses on derivative instruments

     2,588        (2,948)    

Pension liability adjustments

     21,207        (70,355)    
  

 

 

   

 

 
     61,523        (179,972)    
  

 

 

   

 

 

Comprehensive income (loss)

     317,383        (18,002)     -  

Less: Comprehensive income attributable to noncontrolling interests

     18,807        1,745     
  

 

 

   

 

 

Comprehensive income (loss) attributable to Canon Inc.

     298,576        (19,747)     -  
  

 

 

   

 

 

 

- 9 -


CANON INC. AND SUBSIDIARIES

CONSOLIDATED

3.  DETAILS OF SALES

 

Results for the fourth quarter

  Millions of yen        
     Sales by business unit   Three months ended
December 31, 2017
    Three months ended
December 31, 2016
    Change(%)

 

 

 

Office

    493,199          485,850          +       1.5    

Imaging System

    340,920          324,742          +       5.0    

Medical System

    103,682          -            -    

Industry and Others

    205,284          175,634          +       16.9    

Eliminations

    (22,794)         (21,053)           -    
 

 

 

   

 

 

   

 

 

 

Total

    1,120,291          965,173          +       16.1    
 

 

 

   

 

 

   

 

 

 
    Millions of yen        
     Sales by region   Three months ended
December 31, 2017
    Three months ended
December 31, 2016
    Change(%)  

Japan

    242,692          205,096          +       18.3    

Overseas:

       

Americas

    303,277          267,467          +       13.4    

Europe

    289,104          262,324          +       10.2    

Asia and Oceania

    285,218          230,286          +       23.9    
 

 

 

   

 

 

   

 

 

 
    877,599          760,077          +       15.5    
 

 

 

   

 

 

   

 

 

 

Total

    1,120,291          965,173          +       16.1    
 

 

 

   

 

 

   

 

 

 

*Canon newly established “Medical System” Business Unit effective at the beginning of the second quarter of 2017, and certain businesses included in Industry and Others Business Unit have been reclassified. Net sales for the three months ended December 31, 2016 were not restated since they were not material.

 

Results for the fiscal year   Millions of yen        
     Sales by business unit   Year ended
December 31, 2017
    Year ended
December 31, 2016
    Change(%)  

Office

    1,865,928          1,807,819          +       3.2    

Imaging System

    1,136,188          1,095,289          +       3.7    

Medical System

    436,187          -           -    

Industry and Others

    731,704          584,660          +       25.2    

Eliminations

    (89,992)         (86,281)           —    
 

 

 

   

 

 

   

 

 

 

Total

    4,080,015          3,401,487          +       19.9    
 

 

 

   

 

 

   

 

 

 
    Millions of yen        
     Sales by region   Year ended
December 31, 2017
    Year ended
December 31, 2016
    Change(%)  

Japan

    884,828          706,979          +       25.2    

Overseas:

       

Americas

    1,107,515          963,544          +       14.9    

Europe

    1,028,415          913,523          +       12.6    

Asia and Oceania

    1,059,257          817,441          +       29.6    
 

 

 

   

 

 

   

 

 

 
    3,195,187          2,694,508          +       18.6    
 

 

 

   

 

 

   

 

 

 

Total

    4,080,015          3,401,487          +       19.9    
 

 

 

   

 

 

   

 

 

 

 

*Canon newly established “Medical System” Business Unit effective at the beginning of the second quarter of 2017, and certain businesses included in Industry and Others Business Unit have been reclassified. Net sales for the year ended December 31, 2016 were not restated since they were not material.

 

 

Notes:   1.  

 The primary products included in each of the segments are as follows:

Office Business Unit :

Office multifunction devices (MFDs) / Laser multifunction printers (MFPs) / Laser printers / Digital production printing systems /

High speed continuous feed printers / Wide-format printers / Document solutions

Imaging System Business Unit :

Interchangeable lens digital cameras / Digital compact cameras / Digital camcorders / Digital cinema cameras /

Interchangeable lenses / Compact photo printers / Inkjet printers / Large format inkjet printers / Commercial photo printers /

Image scanners / Multimedia projectors / Broadcast equipment / Calculators

Medical System Business Unit :

Digital radiography systems / Diagnostic x-ray systems / Computed tomography / Magnetic resonance imaging /

Diagnostic ultrasound systems / Clinical chemistry analyzers / Ophthalmic equipment

Industry and Others Business Unit :

Semiconductor lithography equipment / FPD (Flat panel display) lithography equipment / Vacuum thin-film deposition equipment /

Organic LED (OLED) panel manufacturing equipment / Die bonders / Micromotors / Network cameras / Handy terminals /

Document scanners

  2.  

 The principal countries and regions included in each regional category are as follows:

Americas: United States of America, Canada, Latin America

Europe: United Kingdom, Germany, France, Netherlands, European countries, Middle East and Africa

Asia and Oceania: China, Asian countries, Australia

 

- 10 -


CANON INC. AND SUBSIDIARIES

CONSOLIDATED

4. CONSOLIDATED STATEMENTS OF EQUITY

Millions of yen

                   
     Common
Stock
    Additional
paid-in
capital
    Legal
reserve
   

Retained

earnings

   

Accumulated

other
comprehensive

income (loss)

    Treasury
stock
    Total Canon
Inc.
shareholders’
equity
   

Noncontrolling

interests

    Total equity

Balance at December 31, 2015

    174,762       401,358       65,289       3,365,158       (29,742     (1,010,410     2,966,415       218,048     3,184,463
                   

Equity transactions with noncontrolling interests and other

      27           258         285       (5,270   (4,985)

Dividends to Canon Inc. shareholders

          (163,810         (163,810     (163,810)

Dividends to noncontrolling interests

                  (4,077   (4,077)

Acquisition of subsidiaries

                  1,047     1,047 

Transfers to legal reserve

        1,269       (1,269              
                   

Comprehensive income:

                   

Net income

          150,650           150,650       11,320     161,970 

Other comprehensive income (loss), net of tax:

                   

Foreign currency translation adjustments

            (101,257       (101,257     (6,409   (107,666)

Net unrealized gains and losses on securities

            1,196         1,196       (199   997 

Net gains and losses on derivative instruments

            (2,924       (2,924     (24   (2,948)

Pension liability adjustments

            (67,412       (67,412     (2,943   (70,355)

Total comprehensive income (loss)

                (19,747     1,745     (18,002)
                   

Repurchases and reissuance of treasury stock

                            (1             (13     (14           (14)

Balance at December 31, 2016

    174,762       401,385       66,558       3,350,728       (199,881     (1,010,423)       2,783,129       211,493     2,994,622 

 

                   

Equity transactions with noncontrolling interests and other

      1               1       (1  

Dividends to Canon Inc. shareholders

          (162,887         (162,887     (162,887)

Dividends to noncontrolling interests

                  (4,814   (4,814)

Acquisition of subsidiaries

                  60     60 

Transfers to legal reserve

        321       (321              
                   

Comprehensive income:

                   

Net income

          241,923           241,923       13,937     255,860 

Other comprehensive income (loss), net of tax:

                   

Foreign currency translation adjustments

            44,168         44,168       2,922     47,090 

Net unrealized gains and losses on securities

            (9,767       (9,767     405     (9,362)

Net gains and losses on derivative instruments

            2,562         2,562       26     2,588 

Pension liability adjustments

            19,690         19,690       1,517     21,207 

Total comprehensive income (loss)

                298,576       18,807     317,383 
                   

Repurchases of treasury stock

              (50,036     (50,036     (50,036)

Reissuance of treasury stock

                            (131             1,978       1,847             1,847 

Balance at December 31, 2017

    174,762       401,386       66,879       3,429,312       (143,228     (1,058,481     2,870,630       225,545     3,096,175 

 

 

- 11 -


CANON INC. AND SUBSIDIARIES

CONSOLIDATED

5. CONSOLIDATED STATEMENTS OF CASH FLOWS

 

     Millions of yen  
     Year ended
    December 31, 2017    
     Year ended
    December 31, 2016    
 

Cash flows from operating activities:

     

Consolidated net income

     255,860         161,970   

Adjustments to reconcile consolidated net income to net cash provided by operating activities:

     

Depreciation and amortization

     261,881         250,096   

Loss on disposal of fixed assets

     6,935         5,203   

Impairment losses on goodwill

     33,912          

Gain on securities contributed to retirement benefit trust

     (17,836)         

Deferred income taxes

     (17,603)        7,188   

(Increase) decrease in trade receivables

     3,563         (4,155)  

Decrease in inventories

     2,967         6,156   

Increase in trade payables

     4,951         56,844   

Increase (decrease) in accrued income taxes

     46,296         (16,456)  

Increase (decrease) in accrued expenses

     18,503         (5,256)  

Increase in accrued (prepaid) pension and severance cost

     522         5,489   

Other, net

     (9,394)        33,204   
  

 

 

    

 

 

 

Net cash provided by operating activities

     590,557         500,283   

Cash flows from investing activities:

     

Purchases of fixed assets

     (189,484)         (206,971)  

Proceeds from sale of fixed assets

     26,444         6,177   

Purchases of available-for-sale securities

     (2,220)         (84)  

Proceeds from sale and maturity of available-for-sale securities

     970         1,181   

Decrease in time deposits, net

     3,373         15,414   

Acquisitions of businesses, net of cash acquired

     (6,557)        (649,570)  

Purchases of other investments

     (928)        (4,460)  

Other, net

     3,392         1,188   
  

 

 

    

 

 

 

Net cash used in investing activities

     (165,010)        (837,125)  

Cash flows from financing activities:

     

Proceeds from issuance of long-term debt

     1,570         610,552   

Repayments of long-term debt

     (126,578)        (856)  

Increase (decrease) in short-term loans, net

     5,628         (80,580)  

Purchases of noncontrolling interests

            (4,993)  

Dividends paid

     (162,887)        (163,810)  

Repurchases and reissuance of treasury stock

     (50,034)        (14)  

Other, net

     (8,163)        (4,607)  
  

 

 

    

 

 

 

Net cash provided by (used in) financing activities

     (340,464)        355,692   

Effect of exchange rate changes on cash and cash equivalents

     6,538         (22,270)  
  

 

 

    

 

 

 

Net change in cash and cash equivalents

     91,621         (3,420)  

Cash and cash equivalents at beginning of year

     630,193         633,613   
  

 

 

    

 

 

 

Cash and cash equivalents at end of year

     721,814         630,193   
  

 

 

    

 

 

 

 

- 12 -


CANON INC. AND SUBSIDIARIES

CONSOLIDATED

6. NOTE FOR GOING CONCERN ASSUMPTION

      Not applicable.

7. SEGMENT INFORMATION

  SEGMENT INFORMATION BY BUSINESS UNIT

 

Results for the fourth quarter    Millions of yen         

 

       Three months ended    
December 31, 2017
         Three months ended    
December 31, 2016
       Change(%)    

Office

        

Net sales:

        
 

External customers

     492,594           484,656             + 1.6   
 

Intersegment

     605           1,194             - 49.3     
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     493,199           485,850             + 1.5   

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     465,909           437,225             + 6.6   

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     27,290           48,625             - 43.9     

 

  

 

 

    

 

 

    

 

 

 

Imaging System

        

Net sales:

        
 

External customers

     340,738           324,455             + 5.0   
 

Intersegment

     182           287             - 36.6     
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     340,920           324,742             + 5.0   

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     281,899           273,040             + 3.2   

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     59,021           51,702             + 14.2   

 

  

 

 

    

 

 

    

 

 

 

Medical System

        

Net sales:

        
 

External customers

     103,508           -           -   
 

Intersegment

     174           -           -   
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     103,682           -           -   

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     98,742           -           -   

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     4,940           -           -   

 

  

 

 

    

 

 

    

 

 

 

Industry and Others

        

Net sales:

        
 

External customers

     183,451           156,062             + 17.6   
 

Intersegment

     21,833           19,572             + 11.6   
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     205,284           175,634             + 16.9   

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     189,183           172,472             + 9.7   

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     16,101           3,162             + 409.2   

 

  

 

 

    

 

 

    

 

 

 

Corporate and Eliminations

        

Net sales:

        
 

External customers

     -           -           -     
 

Intersegment

     (22,794)          (21,053)          -     
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     (22,794)          (21,053)          -     

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     5,522           2,268           -     

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     (28,316)          (23,321)          -     

 

  

 

 

    

 

 

    

 

 

 

Consolidated

        

Net sales:

        
 

External customers

     1,120,291           965,173             + 16.1   
 

Intersegment

     -           -           -     
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     1,120,291           965,173             + 16.1   

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     1,041,255           885,005             + 17.7   

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     79,036           80,168             - 1.4     

 

  

 

 

    

 

 

    

 

 

 

*Canon newly established “Medical System” Business Unit effective at the beginning of the second quarter of 2017, and certain businesses included in Industry and Others Business Unit have been reclassified. Operating results for the three months ended December 31, 2016 were not restated since they were not material.

*Operating results pertaining to TMSC, a company acquired in December 2016, are included in “Medical System” for the fourth quarter of 2017. Amortization costs of identified intangible assets resulting from the purchase price allocation of TMSC are included in “Corporate and Eliminations”.

Reconciliation from Operating profit to Adjusted operating profit

 

         Millions of yen         
         Three months ended    
December 31, 2017
         Three months ended    
December 31, 2016
        

Office

        
 

Operating profit

     27,290         48,625                               
 

Impairment losses on goodwill

     33,912         -        
    

 

 

    

 

 

    
 

Adjusted operating profit

     61,202         48,625      
    

 

 

    

 

 

    

Consolidated

        
 

Operating profit

     79,036         80,168      
 

Impairment losses on goodwill

     33,912         -        
    

 

 

    

 

 

    
 

Adjusted operating profit

     112,948         80,168      
    

 

 

    

 

 

    

 

- 13 -


CANON INC. AND SUBSIDIARIES

CONSOLIDATED

 

 

Results for the fiscal year    Millions of yen         
     Year ended
    December 31, 2017    
     Year ended
    December 31, 2016    
       Change(%)    

Office

        

Net sales:

        
 

External customers

     1,863,688           1,804,862         +         3.3   
 

Intersegment

     2,240           2,957         - 24.2     
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     1,865,928           1,807,819         + 3.2   

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     1,685,280           1,638,333         + 2.9   

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     180,648           169,486         + 6.6   

 

  

 

 

    

 

 

    

 

 

 

Total assets

     962,006           961,749           + 0.0   

Depreciation and amortization

     74,377           78,319           - 5.0     

Capital expenditures

     47,653           72,189           - 34.0     

 

  

 

 

    

 

 

    

 

 

 

Imaging System

        

Net sales:

        
 

External customers

     1,135,584           1,094,291         + 3.8   
 

Intersegment

     604           998         - 39.5     
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     1,136,188           1,095,289         + 3.7   

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     960,275           950,876         + 1.0   

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     175,913           144,413         + 21.8   

 

  

 

 

    

 

 

    

 

 

 

Total assets

     387,088           391,661           - 1.2     

Depreciation and amortization

     41,695           47,386           - 12.0     

Capital expenditures

     28,508           25,564           + 11.5   

 

  

 

 

    

 

 

    

 

 

 

Medical System

        

Net sales:

        
 

External customers

     434,985           -           -     
 

Intersegment

     1,202           -           -     
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     436,187           -           -     

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     413,682           -           -     

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     22,505           -           -     

 

  

 

 

    

 

 

    

 

 

 

Total assets

     238,824           204,755           + 16.6   

Depreciation and amortization

     5,212           -           -     

Capital expenditures

     8,963           -           -     

 

  

 

 

    

 

 

    

 

 

 
Industry and Others         

Net sales:

        
 

External customers

     645,758           502,334         + 28.6   
 

Intersegment

     85,946           82,326         + 4.4   
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     731,704           584,660         + 25.2   

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     674,916           577,212         + 16.9   

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     56,788           7,448         + 662.5   

 

  

 

 

    

 

 

    

 

 

 

Total assets

     360,271           340,455           + 5.8   

Depreciation and amortization

     37,705           41,053           - 8.2     

Capital expenditures

     15,736           29,346           - 46.4     

 

  

 

 

    

 

 

    

 

 

 

Corporate and Eliminations

        

Net sales:

        
 

External customers

     -           -           -     
 

Intersegment

     (89,992)          (86,281)       -     
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     (89,992)          (86,281)       -     

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     14,383           6,200         -     

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     (104,375)          (92,481)       -     

 

  

 

 

    

 

 

    

 

 

 

Total assets

     3,250,102           3,239,909           + 0.3   

Depreciation and amortization

     102,892           83,338           + 23.5   

Capital expenditures

     80,529           81,280           - 0.9     

 

  

 

 

    

 

 

    

 

 

 

Consolidated

        

Net sales:

        
 

External customers

     4,080,015           3,401,487         + 19.9   
 

Intersegment

     -           -           -     
 

 

  

 

 

    

 

 

    

 

 

 
 

Total

     4,080,015           3,401,487         + 19.9   

 

  

 

 

    

 

 

    

 

 

 

Operating cost and expenses

     3,748,536           3,172,621         + 18.2   

 

  

 

 

    

 

 

    

 

 

 

Operating profit

     331,479           228,866           + 44.8   

 

  

 

 

    

 

 

    

 

 

 

Total assets

     5,198,291           5,138,529           + 1.2   

Depreciation and amortization

     261,881           250,096           + 4.7   

Capital expenditures

     181,389           208,379           - 13.0     

 

  

 

 

    

 

 

    

 

 

 

*Canon newly established “Medical System” Business Unit effective at the beginning of the second quarter of 2017, and certain businesses included in Industry and Others Business Unit have been reclassified. Total assets as of December 31, 2016 have been restated to comply with this change. Operating results for the year ended December 31, 2016, however, were not restated since they were not material.

*Operating results pertaining to TMSC, a company acquired in December 2016, are included in “Medical System” for the year ended December 31, 2017. Amortization costs of identified intangible assets resulting from the purchase price allocation of TMSC are included in “Corporate and Eliminations”.

 

- 14 -


CANON INC. AND SUBSIDIARIES

CONSOLIDATED

Reconciliation from Operating profit to Adjusted operating profit

 

     Millions of yen         
     Year ended
    December 31, 2017    
     Year ended
    December 31, 2016    
        

Office

        

Operating profit

     180,648         169,486      

Impairment losses on goodwill

     33,912         -      
  

 

 

    

 

 

    

Adjusted operating profit

     214,560         169,486      
  

 

 

    

 

 

    

Consolidated

        

Operating profit

     331,479         228,866      

Impairment losses on goodwill

     33,912         -      
  

 

 

    

 

 

    

Adjusted operating profit

     365,391         228,866      
  

 

 

    

 

 

    

8. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES

Canon’s consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles.

Recently Issued Accounting Guidance

In January 2017, the Financial Accounting Standards Board issued an amendment which eliminates the second step from the impairment test of goodwill. This amendment requires the entity to recognize an impairment charge for the amount by which the carrying amount exceeds the fair value of reporting unit; however, the impairment charge is limited to the amount of goodwill allocated to that reporting unit. Canon early adopted this amended guidance from the impairment test performed after January 1, 2017.

9. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(1) NET INCOME ATTRIBUTABLE TO CANON INC. SHAREHOLDERS PER SHARE

 

Results for the fiscal year    Millions of yen  
     Year ended
    December 31, 2017    
     Year ended
    December 31, 2016    
 

Net income attributable to Canon Inc.

     

-Basic

     241,923           150,650   

-Diluted

     241,923           150,650   
     Number of shares  

Average common shares outstanding

     

-Basic

     1,085,439,370           1,092,070,680   

-Diluted

     1,085,439,370           1,092,070,680   
     Yen  

Net income attributable to

     

Canon Inc. shareholders per share:

     

-Basic

     222.88           137.95   

-Diluted

     222.88           137.95   

(2) SUBSEQUENT EVENT

 

  There is no significant subsequent event.

 

- 15 -


CANON INC. AND SUBSIDIARIES

CONSOLIDATED

 

Canon has decided to discontinue the disclosure of the below items in this report from this quarter. The information will be disclosed in such other reports as Form 20-F for the year ended December 31, 2017.

-Non-Consolidated Results

-Non-Consolidated Results in Operating Results and Financial Conditions

-Basic Policy Regarding Profit Distribution and Dividends for the Current Fiscal Year in Operating Results and Financial Conditions

-Group Position

-Management Policy

-Group Position in Basis of Presentation and Significant Accounting Policies

-Notes to Consolidated Financial Statements except for Net Income Attributable to Canon Inc. Shareholders per Share and Subsequent

Event

-Note for non-GAAP Financial Measures (Free cash flow)

-Non-Consolidated Financial Statements

In addition, Canon has decided to discontinue the distribution of its “Supplementary Report” within this report. The information will be available in Financial Results and Presentation Materials for fiscal year 2017 on Canon’s website.

 

 

- 16 -


NON-CONSOLIDATED

(Current Titles are Shown in the Parentheses)

Effective Date: March 29, 2018

Audit & Supervisory Board Members

(1) Candidates for new Audit & Supervisory Board Member to be appointed

 

Masaaki Nakamura

  

(Managing Executive Officer, Group Executive of Public Affairs Headquarters)

Koichi Kashimoto

  

(Senior General Manager of The Dai-ichi Life Insurance Company, Limited. / Chief of Dai-ichi Life Holdings, Inc.)

(2) Audit & Supervisory Board Members to be retired

 

Makoto Araki

 

Kuniyoshi Kitamura

 

- 17 -


NON-CONSOLIDATED

(Current Titles are Shown in the Parentheses)

Executive Officers

(1) New Executive Officers to be appointed

Effective date: April 1, 2018

 

Katsuyoshi Soma

   (President of Fukushima Canon Inc.)

Masaki Omori

   (Senior General Manager of Production Engineering Research Laboratory)

(2) Executive Officers to be retired

Effective date: March 31, 2018

 

Rokus van Iperen

   (Senior Managing Executive Officer, President & CEO of Canon Europe Ltd. & Canon Europa N.V.)

Yasuhiro Tani

   (Senior Managing Executive Officer, Group Executive of Digital System Technology Development Headquarters)

Hiroyuki Suematsu

   (Managing Executive Officer, Group Executive of Corporate Planning Development Headquarters)

Effective date: March 29, 2018

 

Masaaki Nakamura

   (Managing Executive Officer, Group Executive of Public Affairs Headquarters)

 

- 18 -